Rechercher par ordre alphabétique

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Retour

Luis Souhami, M.D.

Chercheur, IR-CUSM, site Glen

Programme de recherche sur le cancer

Professeur, Département d'oncologie, Faculté de médecine, Université McGill

 

Mots-clés


tumeurs du système nerveux central • malignités gynécologiques • malignités génito-urinaires

Aire de recherche


Ma recherche porte sur le traitement de tumeurs impliquant le cerveau, les niveaux gynécologique et urogénital.

Publications choisies


Cliquez sur Pubmed pour voir la liste de mes publications

  • Turgeon G-A, Souhami L, Cury FL, Faria SL, Duclos M, Sturgeon J, Kassouf W. Hypofractionated IMRT in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer. Int J Radiat Oncol Biol Phys 88:326-331, 2014. PMID: 24411604.

  • Patel N, Souhami L, Mansure JJ, Duclos M, Aprikian A, Faria S, David M, Cury FL. Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy. Brachytherapy 13:450-455, 2014. PMID: 25023396.

  • Owen S, Souhami L. The management of brain metastases in non-small cell lung cancer. Frontiers in Oncology 4:1-5, 2014. PMCID: PMC4164096.

  • Mason MD, Parulekar WR, Sydes MR, Brundage M, Kirkbride P, Gospodarowicz M, Cowan R, Kostashuk EC, Anderson J, Swanson G, Parmar MK, Hayter C, Jovic G, Hiltz A, Hetherington J, Sathya J, Barber JB, McKenzie M, El-Sharkawi S, Souhami L, Hardman PD, Chen BE, Warde P. Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer. J Clin Oncol. 2015 Feb 17. pii: JCO.2014.57.7510. [Epub ahead of print]. PMID: 25691677.

  • Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer. 2015 Apr 6. doi: 10.1002/cncr.29337. [Epub ahead of print] PMID: 25847373.